Some divalent metal(II) complexes of novel potentially tetradentate Schiff base N,N′‐bis(2‐carboxyphenylimine)‐2,5‐thiophenedicarboxaldhyde: Synthesis,spectroscopic characterization and bioactivities

A novel tetradentate dianionic Schiff base ligand, N ,N ′‐bis(2‐carboxyphenylimine)‐2,5‐thiophenedicarboxaldhyde (H₂L) and some first row d‐transition metal chelates (Co(II), Cu(II), Ni(II) and Zn(II)) were synthesized and characterized using various physicochemical and spectroscopic methods. The spectroscopic data suggested that the parent Schiff base ligand coordinates through both deprotonated carboxylic oxygen and imine nitrogen atoms. The free Schiff base and its metal chelates were screened for their antimicrobial activities for various pathogenic bacteria and fungi using the agar well diffusion method. The antibacterial and antifungal activities of all the newly synthesized compounds are significant compared to the standard drugs ciprofloxacin and nystatin. The antioxidant activities of the compounds were determined by reduction of 1,1‐diphenyl‐2‐picrylhydrazyl and compared with that of vitamin C as a standard. DNA binding ability of the novel Schiff base and its complexes was investigated using absorption spectroscopy, fluorescence spectroscopy, viscosity measurements and thermal denaturation. The obtained results clearly demonstrate that the binding affinity with calf thymus DNA follows the order: Cu(II) complex > Ni(II) complex > Zn(II) complex > Co(II) complex >H₂L. Furthermore, the DNA cleavage activity of the newly synthesized ligand and its metal complexes was investigated using supercoiled plasmid DNA (pUC18) gel electrophoresis.     

New metal(II) complexes with ceftazidime Schiff base

Complexes of Co(II), Ni(II) and Cu(II) with the Schiff base (LH) derived from ceftazidime and salicylaldehyde were synthesized. The proposed structures of the new metal complexes based on the results of elemental analyses, molar conductivity, IR, DRUV and ¹H NMR spectra, effective magnetic moment and thermal analysis were discussed. The surface morphology of Schiff base and metal complexes was studied by SEM. The composition of the metal complexes was ML₂, where L is the deprotonated Schiff base ligand and M = Co(II), Ni(II) and Cu(II). IR spectral data indicated the Schiff base ligand being bidentately coordinated to the metallic ions with N and O atoms from azomethine and phenolic groups. All the complexes have square-planar geometry and are nonelectrolytes. The thermal analysis recorded that TG, DTG, DTA and DSC experiments confirmed the assigned composition and gave information about the thermal stability of complexes in dynamic air atmosphere. Theoretical investigation of the molecular structure of Schiff base ligand and its complexes was studied using programs dedicated to chemical modeling and quantomolecular calculation of chemical properties. The newly synthesized complexes were tested for in vitro antibacterial activity against selected Gram-negative and Gram-positive bacterial strains, and they exhibited an antibacterial activity superior to that of the Schiff base ligand.     

Biomolecular docking,antimicrobial and cytotoxic studies on new bidentate schiff base ligand derived metal (II) complexes

Three new metal complexes [Cu(L)₂] (1), [Co(L)₂] (2) and [Zn(L)₂] (3) have been prepared by the reaction of hydrated salts of metal (II) acetate with new Schiff base ligand HL, [2‐((4‐(dimethylamino)phenylimino)methyl)‐4,6‐di‐t‐butylphenol] and characterized by different physico‐chemical analyses such as elemental analysis, single XRD, ¹H NMR, FTIR and UV–Vis spectroscopic techniques. Their biomolecular docking, antimicrobial and cytotoxicity studies have also been demonstrated. The proposed structure of Schiff base ligand HL and complex 2 are confirmed by Single crystal X‐ray crystallography study. This analysis revealed that metal (II) complexes remain in distorted tetrahedral coordination environments. The electronic properties such as HOMO and LUMO energies are carried out by gaseous phase DFT/B3LYP calculations using Gaussian 09 program. Complex 1 showed a good binding propensity to the DNA and HSA, during the assessment of docking studies. Schiff base ligand HL and its metal (II) complexes, 1–3 screened for their in vitro antimicrobial activities using the disc diffusion method against selected microbes. Complex 1 shows higher antimicrobial activity than complexes 2, 3 and Schiff base ligand HL. According to the results obtained from the cytotoxic studies, Schiff base ligand HL and its metal (II) complexes 1–3 have better cytotoxicity against MCF‐7 cell lines with potency higher than the currently used chemotherapeutic agent cyclophosphamide.     

Synthesis,characterization, antimicrobial and diuretic study of Mg(II), Mn(II), Fe(II) and VO(II) complexes of chemotherapeutic importance

The synthesis, characterization and diuretic activity of four new biologically active complexes of Mg(II) and VO(II) with bidentate Schiff base ligand acetazolamide–salicylaldimine (L) obtained from the inserted condensation of 5-acetamido-1,3,4-thiadiazole-2-sulphonamide (acetazolamide) with salicylaldehyde in a 1:1 molar ratio have been reported. Using this bidentate ligand complexes of Mg(II), Mn(II), Fe(II) and VO(II) with general formula ML₂ have been synthesized. The synthesized complexes were characterized by several techniques using elemental analysis, FT-IR, electronic spectra, TGA, mass, particle size analysis and molar conductance measurements. The elemental analysis data suggest the stoichiometry to be 1:2 [M:L]. The molar conductance measurements suggest non-electrolytic nature of the complexes. Infrared spectral data agreed with the coordination to the central metal ion through deprotonated phenolic oxygen and azomethine nitrogen atoms. On the basis of spectral studies, octahedral geometry is suggested for Mg(II), Mn(II), Fe(II) and square pyramidal geometry is suggested for VO(II) complexes. The pure drug, synthesized ligand and metal(II) complexes were screened for their antimicrobial activities against Eschericia coli, Bacillus subtilis, Aspergillus niger and Aspergillus flavous. The results show that the metal complexes were more active than the ligand and pure drug against these microbial species as expected. The ligand and its Mg(II) complexes was screened for their diuretic activity also.     

Chromone-based Schiff base metal complexes as catalysts for catechol oxidation: Synthesis,kinetics and electrochemical studies

Two new Schiff base ligands with chromone moiety and their transition metal complexes were synthesized and characterized by elemental analyses, magnetic susceptibility, molar conductance and TGA analyses, FT IR, UV-Vis, NMR and mass spectroscopy. All the complexes synthesized have been investigated as functional models for catechol oxidase (catecholase) activity by employing 3,5-di-tert-butylcatechol as a model substrate. The two mononuclear copper(II) and two mononuclear iron(II) complexes show catecholase activity with turnover (k_cat) numbers lying in the range 27.2–1328.4 h^?1. According to the kinetic measurement results, the rate of catechol oxidation follows first order kinetics and iron(II) complexes were found to have higher catalytic activity than those of copper(II) complexes. Electron-donating substituent on Schiff base ligand enhanced the catalytic activity of metal complexes while the electron-withdrawing substituent led to a decrease in activity. The electrochemical properties of two Schiff bases and their metal complexes were also investigated by Cyclic Voltammetry (CV) using glassy carbon electrode (GCE) at various scan rates. Electrochemical processes of all the compounds were observed as irreversible.     

New azo‐azomethine‐based transition metal complexes: Synthesis,spectroscopy, solid‐state structure,density functional theory calculations and anticancer studies

A novel tetradentate azo‐Schiff base ligand (H₂L) was synthesized by 2:1 molar condensation of an azo‐aldehyde and ethylenediamine. Its mononuclear Cu(II), Ni(II), Co(II) and Zn(II) complexes were prepared and their structures were confirmed using elemental analysis, NMR, infrared and UV–visible spectroscopies and molar conductivity measurements. The results suggest that the metal ion is bonded to the tetradentate ligand through phenolic oxygens and imine nitrogens of the ligand. The solid‐state structures of the azo‐Schiff base ligand and its Cu(II) complex were determined using single‐crystal X‐ray diffraction studies. The azo‐Schiff base ligand lies on a crystallographic inversion centre and thus the asymmetric unit contains half of the molecule. X‐ray data revealed that keto–amine tautomer is favoured in the solid‐state structure of the ligand. In the structure of the Cu(II) complex, the Cu(II) ion is coordinated to two phenolate oxygen atoms and two imine nitrogen atoms of the azo‐Schiff base ligand with approximate square planar geometry. The anticancer activity of the synthesized complexes was investigated for human cancer cell line (MCF‐7) and cytotoxicity of the synthesized compounds was determined against mouse fibroblast cells (L929). The ligand and its complexes were found to show antitumor activity. The synthesized metal complexes were optimized at the B3LYP/LANL2DZ level and a new theoretical formula for MCF‐7 cells was also derived.     

Cyclometalated complexes containing ferrocenyl Schiff base: Preparation,characterization, DFT calculations,application in cancer and biological researches and MOE studies

A series of transition metal (II/III) complexes containing organometallic Schiff base ligand (H₂L) had been synthesized and characterized by using elemental analysis (C, H, N, M), molar conductivity, IR, UV–Vis, ¹H NMR and mass spectral analysis. Also, their TG and DTG behaviors were investigated. The ligand was prepared by condensation of 4-aminosalicylic acid with 2-acetylferrocene in 1:1 M ratio. The data of elemental analysis indicated that the prepared complexes were synthesized also in a 1:1 M ratio. The ligand behaved as neutral bidentate ligand that coordinated to metal ions through protonated O-phenolic and protonated carboxylic-OH groups. All complexes had octahedral structure. DFT calculations for H₂L ligand were determined with some parameters such as HOMO-LUMO energy gab, electronegativity and chemical hardness–softness. Antimicrobial activity of both H₂L Schiff base ligand and its metal complexes was tested against different strains of bacteria and fungi species. Furthermore, all compounds had been screened for their anticancer activities against breast cancer (MCF-7) cell line. [Cu(H₂L)(H₂O)₂Cl₂]·2H₂O complex had the lowest IC₅₀ value = 47.3 µg/mL. For determining the more effective and probable binding mode between the H₂L ligand, Co(II) and Zn(II) complexes with different active sites of 4K3V, 2YLB and 3DJD receptors, so molecular docking studies were investigated.     

A modern technique for preparation of zinc(II) and nickel(II) nanometric oxides using Schiff base compounds: synthesis,characterization, and antibacterial properties

The purpose of the work reported in this paper was the preparation and characterization of Zn(II) and Ni(II) nanometric oxides by using a simple Schiff compound as precursor for complexation then thermal degradation at 600 °C. Metal complexes [Ni(L)₂(Cl)₂] and [Zn(L)₂](NO₃)₂, where L is the Schiff base formed by condensation of 2-thiophenecarboxaldehyde with phenylhydrazine, were prepared and characterized by elemental analysis and by magnetic and spectroscopic measurements (infrared, Raman, X-ray powder diffraction, and scanning electron microscopy). Elemental analysis of the chelates suggests the stoichiometry is 1:2 (metal–ligand). Infrared spectra of the complexes are indicative of coordination of the nitrogen of the phenylhydrazine (–Ph–NH–) group and the sulfur atom of the thiophene ring with the central metal atom. Magnetic susceptibility data and electronic and ESR spectra suggest a distorted octahedral structure for the Ni(II) complex and tetrahedral geometry for the Zn(II) complex. The Schiff base and its metal chelates were screened for in-vitro activity against four bacteria, two Gram-positive (Bacillus subtilis and Staphylococcus aureus) and two Gram-negative (Escherichia coli and Pseudomonas aeruginosa), and two strains of fungus (Aspergillus flavus and Candida albicans). The metal chelates were shown to have greater antibacterial activity than the free Schiff-base chelate.     

Spectroscopic,thermal, biological activity,molecular docking and density functional theoretical investigation of novel bis Schiff base complexes

New Schiff base ligand (H₂L, 1,2‐bis[(2‐(2‐hydroxyphenylimino)‐methyl)phenoxy]ethane) came from condensation reaction of bisaldehyde and 2‐aminophenol was synthesized in a molar ratio 1:2. Metal complexes and the ligand were completely discussed with spectroscopic and theoretical mechanism. The complexes with Fe(III), Cr(III), Mn(II), Co(II), Cu(II), Ni(II), Th(IV) and Zn(II) have been discussed and characterized by elemental analyses, molar conductance, IR, mass spectroscopy, thermal, magnetic measurements, and ¹H NMR. The results proved that the Schiff base was a divalent anion with hexadentate O₄N₂ donors came from the etheric oxygens (O1, O2), azomethine nitrogens (N1, N2) and deprotonated phenolic oxygens (O3, O4). Density Functional Theory using (B3LYP/6‐31G*) level of theory were implemented to predict molecular geometry, Mulliken atomic energetic and charges of the ligand and complexes. The calculation display that complexes had weak field ligand. The binding energy ranged from 650.5 to 1499.0 kcal/mol for Mn(II) and Th(IV) complexes, respectively. The biological behavior of the Schiff base ligand and its metal complexes were displayed against bacteria and fungi organisms. Fe(III) complex gave remarkable biological activity in comparison with the parent bis Schiff base.     

Coordination compounds of some transition metal ions with new Schiff base ligand derived from dibenzoyl methane. Structural characterization,thermal behavior,molecular structure,antimicrobial, anticancer activity and molecular docking studies

Series of Cr(III), Mn(II), Fe(III), Co(II), Ni(II), Cu(II), Zn(II) and Cd(II) complexes were prepared with tetradentate Schiff base ligand derived by condensation of 2‐aminophenol with dibenzoylmethane. The novel Schiff base H₂L (2–2′‐((1Z,1Z’)‐(1,3‐diphenyl propane‐1,3 diylidene) bis (azanylylidene) diphenol) and its binary metal complexes were characterized by physicochemical procedures i.e. elemental analysis, FT‐IR, UV–Vis, thermal analyses (TGA/DTG), mass spectrometry, magnetic susceptibility and conductometric measurements. On the basis of these studies, an octahedral geometry for all these complexes was proposed expect Ni(II) complex which had tetrahedral geometry. Molar conductivity values revealed that the complexes were electrolytes except Mn(II), Zn(II) and Cd(II) complexes were non electrolytes. The ligand bound to the metal ions via two azomethine N and two phenolic OH as indicated from the IR and ¹H NMR spectral study. The molecular and electronic structures of H₂L and its zinc complex were optimized theoretically and the quantum chemical parameters were calculated. The antimicrobial activity against a number of bacterial organisms as Streptococcus pneumonia, Bacillus Subtilis, Pseudomonas aeruginosa and Escherichia coli and fungi as Aspergillus fumigates, Syncephalastrum racemosum, Geotricum candidum and Candida albicans by disk diffusion method were screened for the Schiff base and its complexes. The Cd(II) complex has potent antimicrobial activity. Anticancer activity of the Schiff base ligand and its metal complexes were evaluated in human cancer (MCF‐7 cells viability). The Cr(III) complex exhibited higher activity than other complexes and ligand. Molecular docking was used to predict the binding between Schiff base ligand (H₂L) and its Zn(II) complex and the receptors of RNA of amikacin antibiotic (4P20) and human‐DNA‐Topo I complex (1SC7). The docking study provided useful structural information for inhibition studies.     

Design,synthesis, DNA binding ability,chemical nuclease activity and antimicrobial evaluation of Cu(II), Co(II), Ni(II) and Zn(II) metal complexes containing tridentate Schiff base

A novel Schiff base has been designed and synthesized using the bioactive ligand obtained from 4-aminoantipyrine, 3,4-dimethoxybenzaldehyde and 2-aminobenzoic acid. Its Cu(II), Co(II), Ni(II), Zn(II) complexes have also been synthesized in ethanol medium. The structural features have arrived from their elemental analyses, magnetic susceptibility, molar conductance, mass, IR, UV–Vis, ¹H NMR and ESR spectral studies. The data show that the complexes have composition of ML₂ type. The electronic absorption spectral data of the complexes suggest an octahedral geometry around the central metal ion. The interaction of the complexes with calf thymus (CT) DNA has been studied using absorption spectra, cyclic voltammetric, and viscosity measurement. The metal complexes have been found to promote cleavage of pUC19 DNA from the super coiled form I to the open circular form II. The complexes show enhanced antifungal and antibacterial activities compared with the free ligand.     

Bioactive Co(II), Ni(II), and Cu(II) Complexes Containing a Tridentate Sulfathiazole-Based (ONN) Schiff Base

New Co(II), Ni(II), and Cu(II) complexes were synthesized with the Schiff base ligand obtained by the condensation of sulfathiazole with salicylaldehyde. Their characterization was performed by elemental analysis, molar conductance, spectroscopic techniques (IR, diffuse reflectance and UV–Vis–NIR), magnetic moments, thermal analysis, and calorimetry (thermogravimetry/derivative thermogravimetry/differential scanning calorimetry), while their morphological and crystal systems were explained on the basis of powder X-ray diffraction results. The IR data indicated that the Schiff base ligand is tridentate coordinated to the metallic ion with two N atoms from azomethine group and thiazole ring and one O atom from phenolic group. The composition of the complexes was found to be of the [ML₂]∙nH₂O (M = Co, n = 1.5 (1); M = Ni, n = 1 (2); M = Cu, n = 4.5 (3)) type, having an octahedral geometry for the Co(II) and Ni(II) complexes and a tetragonally distorted octahedral geometry for the Cu(II) complex. The presence of lattice water molecules was confirmed by thermal analysis. XRD analysis evidenced the polycrystalline nature of the powders, with a monoclinic structure. The unit cell volume of the complexes was found to increase in the order of (2) < (1) < (3). SEM evidenced hard agglomerates with micrometric-range sizes for all the investigated samples (ligand and complexes). EDS analysis showed that the N:S and N:M atomic ratios were close to the theoretical ones (1.5 and 6.0, respectively). The geometric and electronic structures of the Schiff base ligand 4-((2-hydroxybenzylidene) amino)-N-(thiazol-2-yl) benzenesulfonamide (HL) was computationally investigated by the density functional theory (DFT) method. The predictive molecular properties of the chemical reactivity of the HL and Cu(II) complex were determined by a DFT calculation. The Schiff base and its metal complexes were tested against some bacterial strains (Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Bacillus subtilis). The results indicated that the antibacterial activity of all metal complexes is better than that of the Schiff base.     

Synthesis,characterization, antifungal,antibacterial and DNA cleavage studies of some heterocyclic Schiff base metal complexes

Co(II), Ni(II), Cu(II) and Zn(II) complexes of the Schiff base derived from indole-3-carboxaldehyde and m-aminobenzoic acid were synthesized and characterized by elemental analysis, molar conductance, IR, UV–Vis, magnetic moment, powder XRD and SEM. The IR results demonstrate the bidentate binding mode of the ligand involving azomethine nitrogen and carboxylato oxygen atoms. The electronic spectral and magnetic moment results indicate that Co(II) and Ni(II) complexes have tetrahedral geometry, while Cu(II) complex is square planar. Powder XRD and SEM indicate the crystalline state and surface morphology studies of the complexes. The antimicrobial activity of the synthesized ligand and its complexes were screened by disc diffusion method. The results show that the metal complexes were found to be more active than the ligand. The nuclease activity of the ligand and its complexes were assayed on CT DNA using gel electrophoresis in the presence of H₂O₂. The Cu(II) complex showed increased nuclease activity in the presence of an oxidant when compared to the ligand and other complexes.     

Spectroscopic and thermal characterization of biologically and anticancer active novel Schiff base metal complexes

The novel Schiff base ligand 2,2′-((1Z,1′Z)-(1,3-phenylenebis(azanylylidene))-bis(phenylmethanylylidene))dibenzoic acid (H₂L) was obtained by the condensation of m-phenylenediamine with o-benzoylbenzoic acid. The molecular and electronic structure of Schiff base ligand (H₂L) was optimized theoretically, and the quantum chemical parameters are calculated. Molecular docking was used to predict the binding between Schiff base ligand (H₂L) and the receptors of breast cancer mutant 3hb5-oxidoreductase, crystal structure E. coli (3t88) and crystal structure of S. aureus (3q8u). The newly synthesized Cr(III), Mn(II), Fe(III), Co(II), Ni(II), Cu(II), Zn(II), and Cd(II) complexes were characterized by elemental microanalysis, molar conductance, spectroscopic techniques (IR, ¹H NMR, ESI-mass, ESR, UV–Vis), magnetic susceptibility, thermal (TG/DTG) and powder X-ray diffraction data to explicate their structures. The data showed that the complexes had composition of MH₂L type. The IR results confirmed the bidentate binding of the ligand involving two azomethine nitrogens. ¹H NMR spectral data of the ligand (H₂L) and its Zn(II) and Cd(II) complexes agreed well with the proposed structures. On the basis of electronic spectra and the magnetic measurements, octahedral geometry of the complexes was proposed. Thermogravimetric data (TG and DTG) were also studied. The kinetic and thermodynamic parameters for thermal decomposition of the complexes were calculated using the Coats–Redfern and Horowitz–Metzger methods. In order to appraise the effect of antimicrobial activity of metal ions upon chelation, the newly synthesized ligand and its metal complexes were screened against a number of bacteria organisms as Bacillus subtilis, Staphylococcus aureus, Escherichia coli, and Neisseria gonorrhoeae and against one fungus, Candida albicans, to assess their inhibiting potential by using the disc diffusion method. The results showed that in some cases the antimicrobial activity of complexes was more biologically active than the Schiff base ligand. Anticancer activity of the ligand and its metal complexes were evaluated in human cancer (MCF-7 cells viability). It was found that [Cd(H₂L)(H₂O)₂Cl₂]2H₂O complex showed lowest IC₅₀ than the others, and hence was the more active. The activity index was calculated.     

Synthesis,characterization, and biological activity of some transition metal complexes with Schiff base ligands derived from 4-amino-5-phenyl-4<Emphasis Type="Italic">H</Emphasis>-1,2,4-triazole-3-thiol and salicaldehyde

Abstract  

The coordination behaviour of a Schiff base with SNO donation sites, derived from condensation of 4-amino-5-phenyl-4H-1,2,4-triazole-3-thiol and salicaldehyde, towards some bi- and trivalent metal ions, namely Cr(III), Mn(II), Fe(III), Co(II) (Cl, ClO₄), Ni(II) (Cl, ClO₄), Cu(II), and Zn(II), is reported. The metal complexes were characterized on the basis of elemental analysis, IR, ¹H NMR, solid reflectance, magnetic moment, molar conductance, and thermal analyses (TG, DTG, and DTA). The ionization constant of the Schiff base under investigation and the stability constants of its metal chelates were calculated pH-metrically at 25 °C and ionic strength μ = 0.1 M in 50% (v/v) ethanol–water mixture. The chelates were found to have octahedral (Mn(II)), trigonal bipyramidal (Co(II), Ni(II), Zn(II)), and tetrahedral (Cr(III), Fe(III), and Cu(II)) structures. The ligand and its binary chelates were subjected to thermal analyses and the different thermodynamic activation parameters were calculated from their corresponding DTG curves to throw more light on the nature of changes accompanying the thermal decomposition process of these compounds. The free Schiff base ligand and its metal complexes were tested in vitro against Aspergillus flavus, Candida albicans, C. tropicalis, and A. niger fungi and Bacillus subtilis and Escherichia coli bacteria in order to assess their antimicrobial potential. The results indicate that the ligand and its metal complexes possess antimicrobial properties.     

Preparation,characterization of some transition metal complexes of hydrazone derivatives and their antibacterial and antioxidant activities

A new series of metal complexes of Pd(II), Cd(II) and Cu(II, I) of polydentate Schiff base ligand (H₂L), namely ((Z)-2-(phenylamino)-N'-(thiophen-2-ylmethylene) acetohydrazide) have been prepared. The ligand and its metal complexes have been characterized based on various physicochemical studies as elemental analyses, molar conductance, spectral (UV–Vis, MS, IR, ¹H NMR, ¹³C NMR and XRD), magnetic moment measurements and thermal studies (TG, DTG). In the view of previous studies, the ligand (H₂L) acts as polydentate one and coordinates with metal ions to form all metal complexes. The kinetic and thermodynamic parameters of decomposition process (ΔG, ΔH, ΔS) were calculated. The possible structures of the metal complexes have been computed using the molecular mechanic calculations using the hyper chem. 8.03 molecular modeling program. The calculations are performed to obtain the optimized molecular geometry. The antibacterial study of the selected compounds was assayed against two pathogenic bacteria. Moreover, the complexes (Cu II, I), Cd(II), Pd(II)) and the ligand revealed excellent antioxidant properties and could be useful in fighting the free radicals which occur in close connection with cancerous cells. It was remarkable that the two complexes (Cu II, I) demonstrated stronger antioxidant effects than their parent compounds. It is clear that the new complexes are good active compounds for use in a variety of applications.     

Synthesis,characterization, spectroscopic and theoretical studies of transition metal complexes of new nano Schiff base derived from l‐histidine and 2‐acetylferrocene and evaluation of biological and anticancer activities

A new Schiff base derived from the condensation of 2‐acetylferrocene with l ‐histidine was prepared and characterized using elemental analyses and spectroscopic methods. Cr(III), Mn(II), Fe(III), Co(II), Ni(II), Cu(II), Zn(II) and Cd(II) complexes of the Schiff base were prepared and characterized using various physicochemical methods such as elemental analysis, Fourier transform infrared and UV–visible spectroscopies, molar conductance, thermal analysis and scanning electron microscopy (SEM). Both ligand and complexes were investigated for their biological and anticancer activities. The elemental analyses showed that complexes were formed in a metal‐to‐ligand ratio of 1:1 stoichiometry. The spectral analyses proved that the ligand was tridentate and all complexes had an octahedral geometry, except the Zn(II) complex that was tetrahedral. SEM showed that the ligand and its Cd(II) complex were of nanometric structure. The molecular and electronic structure of the free ligand was optimized theoretically and the quantum chemical parameters were calculated. The molecular structure can be used to investigate the coordination sites and the total charge density around each atom. According to anticancer studies, Cd(II) complex was recommended to be used as anti‐breast cancer drug as it had very low IC₅₀ (3.5 μg ml^?1). Molecular docking was used to predict the binding between the free ligand and its Cd(II) complex and crystal structure of Staphylococcus aureus (PDB ID: 3Q8u), receptors of breast cancer mutant oxidoreductase (PDB ID: 3Hb5) and crystal structure of Escherichia coli (PDB ID: 3 T88) and to identify the binding mode and the crucial functional groups interacting with the three proteins.     

Synthesis,characterization of Schiff base metal complexes and their biological investigation

A new Schiff base ligand named (E)‐2‐(((3‐aminophenyl)imino)methyl)phenol (HL) was prepared through condensation reaction of m‐phenylenediamine and 2‐hydroxybenzaldehyde in 1:1 molar ratio. The new ligand was characterized by elemental analysis and spectral techniques. The coordination behavior of a series of transition metal ions named Cr (III), Mn (II), Fe (III), Co (II), Ni (II), Cu (II), Zn (II) and Cd (II) with the newly prepared Schiff base ligand (HL) is reported. The nature of bonding and the stereochemistry of the complexes have been deduced from elemental analyses, IR, UV–Vis, ¹H NMR, mass, electronic spectra, magnetic susceptibility and conductivity measurements and further their thermal stability was confirmed by thermogravimetric analysis (TG). From IR spectra, it was observed that the ligand is a neutral tridentate ligand coordinates to the metal ions through protonated phenolic oxygen, azomethine nitrogen and nitrogen atom of NH₂ group. The existence, the number and the position of the water molecules was studied by thermal analysis. The molecular structures of the Schiff base ligand (HL) and its metal complexes were optimized theoretically and the quantum chemical parameters were calculated. The synthesized ligand and its complexes were screened for antimicrobial activities against bacterial species (Staphylococcus aureus and Bacillis subtilis, (gram positive bacteria)), (Salmonella SP., Escherichia coli and Pseudomonas aeruginosa, (gram negative bacteria)) and fungi (Aspergillus fumigatus and Candida albicans). The complexes were found to possess high biological activities against different organisms. Molecular docking was used to predict the efficiency of binding between Schiff base ligand (HL) and both receptors of Escherichia coli (3 T88) and Staphylococcus aureus (3Q8U). The receptor of Escherichia coli (3 T88) showed best interaction with Schiff base ligand (HL) compared to receptor of Staphylococcus aureu (3Q8U).     

Syntheses, characterization, antimicrobial and genotoxic activities of new Schiff bases and their complexes

Two new Schiff base ligands (L¹, L²) have been prepared from the reaction of 2,6-diacetylpyridine and 2-pyridinecarboxyaldehyde with 4-amino-2,3-dimethyl-1-phenyl-3-pyrozolin-5-on, and their Co(II), Cu(II), Ni(II), Mn(II), and Cr(III) metal complexes have also been prepared. The complexes are formed by coordination of N and O atoms of the ligands. Their structures were characterized by physico-chemical and spectroscopic methods. The analytical data shows that the metal to ligand ratio in the Schiff base complexes is 1:2. The Schiff base ligands and all complexes were evaluated for their in vitro antibacterial and antifungal activities by the disc diffusion method. In addition, the genotoxic properties of the ligands were studied.     

Physicochemical characterization of nanobidentate ferrocene‐based Schiff base ligand and its coordination complexes: Antimicrobial,anticancer, density functional theory,and molecular operating environment studies

A novel bidentate Schiff base ligand (HL, Nanobidentate Ferrocene based Schiff base ligand L (has one replaceable proton H)) was prepared via the condensation of 2‐amino phenol with 2‐acetyl ferrocene. The ligand was characterized using elemental analysis, mass spectrometry, infrared (IR) spectroscopy, ¹proton nuclear magnetic resonance (H‐NMR) spectroscopy, scanning electron microscopy (SEM), and thermal analysis. The corresponding 1:1 metal complexes with some transition‐metal ions were additionally characterized by their elemental analysis, molar conductance, SEM, and thermogravimetric ana1ysis (TGA). The complexes had the general formula [M(L)(Cl)(H₂O)₃]xCl·nH₂O (M = Cr(III), Mn(II), Fe(III), Co(II), Ni(II), Cu(II), Zn(II), and Cd(II)), (x = 0 for Mn(II), Co(II), Ni(II), Cu(II), Zn(II), and Cd(II), x = 1 for Cr(III) and Fe(III)), (n = 1 for Cr(III), n = 3 for Mn(II) and Co(II), n = 4 for Fe(III), Ni(II), Cu(II), Zn(II), and Cd(II)). Density functional theory calculations on the HL ligand were also carried out in order to clarify molecular structures by the B31YP exchange‐correlation function. The results were subjected to molecular orbital diagram, highest occupied mo1ecu1ar orbital–lowest occupied molecular orbital, and molecular electrostatic potential calculations. The parent Schiff base and its eight metal complexes were assayed against four bacterial species (two Gram‐negative and two‐Gram positive) and four different antifungal species. The HL ligand was docked using molecular operating environment 2008 with crystal structures of oxidoreductase (1CX2), protein phosphatase of the fungus Candida albicans (5JPE), Gram(?) bacteria Escherichia coli (3T88), Gram(+) bacteria Staphylococcus aureus (3Q8U), and an androgen‐independent receptor of prostate cancer (1GS4). In order to assess cytotoxic nature of the prepared HL ligand and its complexes, the compounds were screened against the Michigan cancer foundation (MCF)‐7 breast cancer cell line, and the IC₅₀ values of compounds were calculated.